Showing results (1-10 of 71) with videos related to
Sort By:
Pageof 8
Cancer Immunology, Immunotherapy : CII|December 2, 2010
Experimental immunotherapy for malignant glioma: lessons from two decades of research in the GL261 modelWim Maes, Stefaan W Van GoolImmunotherapy|August 3, 2012
Treg infiltration in glioma: a hurdle for antiglioma immunotherapyLien Vandenberk, Stefaan W Van GoolOncoimmunology|February 7, 2014
Dendritic cell-based immunotherapy in ovarian cancerAn Coosemans, Ignace Vergote, Stefaan W Van GoolEuropean Urology|February 10, 2009
Vaccine therapy in patients with renal cell carcinomaHein Van Poppel, Steven Joniau, Stefaan W Van GoolImmunotherapy|July 20, 2010
Blocking costimulatory pathways: prospects for inducing transplantation toleranceBert Verbinnen, Stefaan W Van Gool, Jan L CeuppensExpert Review of Anticancer Therapy|July 1, 2020
Position paper: new insights into the immunobiology and dynamics of tumor-host interactions require adaptations of clinical studiesTobias Sprenger, Volker Schirrmacher, Wilfried Stücker, et al.Biomedicines|July 29, 2020
Evidence-Based Medicine in Oncology: Commercial Versus Patient BenefitVolker Schirrmacher, Tobias Sprenger, Wilfried Stuecker, et al.Child'S Nervous System : Chns : Official Journal of the International Society for Pediatric Neurosurgery|September 29, 2004
Immunotherapy for malignant gliomas: emphasis on strategies of active specific immunotherapy using autologous dendritic cellsSteven De Vleeschouwer, Stefaan W Van Gool, Frank Van CalenberghAnticancer Research|April 7, 2019
Immune Phenotype Correlates With Survival in Patients With GBM Treated With Standard Temozolomide-based Therapy and ImmunotherapyMarkos Antonopoulos, Stefaan W VAN Gool, Dimitra Dionysiou, et al.Expert Review of Neurotherapeutics|April 8, 2011
Galectin-1 and immunotherapy for brain cancerTina Verschuere, Steven De Vleeschouwer, Florence Lefranc, et al.Pageof 8